Benefits of Neoadjuvant Chemoimmunotherapy Confirmed in Early NSCLC
Neoadjuvant chemoimmunotherapy improves outcomes over chemotherapy alone in patients with early-stage NSCLC, according to a meta-analysis.
Neoadjuvant chemoimmunotherapy improves outcomes over chemotherapy alone in patients with early-stage NSCLC, according to a meta-analysis.
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
R. Lor Randall, MD, FACS, detailed research into the relationship between guideline-concordant care and survival outcomes in patients with osteosarcoma in California.
A dual-recombinase reversible knock-in/knock-out mouse model of Jak2V617F validates the absolute requirement of Jak2V617F in sustaining myeloproliferative neoplasms and provides rationale for the clinical development…
Background: Undifferentiated pleomorphic sarcomas (UPSs) are amongst the most common subtypes of soft-tissue sarcomas. Few real-world data on the use of immune checkpoint blockade (ICB)…
Register for ASTRO’s radiopharmaceutical webinar series.
Although the sample size for this trial was small, data still highlight a potential benefit with nivolumab in dMMR uterine and ovarian cancers.
Join ASTCT Director of Government Relations, Alycia Maloney, JD, and the reimbursement and policy advisors to ASTCT from Nimitt Consulting, for the Medicare FY 2025…
Abstract. The NCI’s Cloud Resources (CR) are the analytical components of the Cancer Research Data Commons (CRDC) ecosystem. This review describes how the three CRs…
Abstract. The NCI Cancer Research Data Commons (CRDC) is a collection of data commons, analysis platforms, and tools that make existing cancer data more findable…
Conformationally insensitive nanobodies activate VWF binding of platelets by disrupting its NAIM.Conformationally sensitive nanobodies inhibit VWF binding